Its certainly clear that theres a lot of pain and suffering involved with Alzheimers, and Alzheimers drugs have consistently come up short when it comes to curing the disease
At the 12-month follow-up : 87.5% of patients reported significant relief defined as 50% reduction in baseline pain scores Mean VAS pain score dropped from 7.2 at baseline to 2.8 at 12 months KOOS (Knee Injury and Osteoarthritis Outcome Score) improved across all subscales: pain, symptoms, activities of daily living, sport/recreation, and quality of life No serious adverse events were reported across the treatment period The durability of the response at 12 months is particularly notable
Monte TL, Rieder CRM, Tort AB, Rockenback I, Pereira ML, Silveira I, et al
But none of the above
While these interventions provide temporary relief for many people, they do not always lead to complete resolution
Pharmaceutical-grade BPC-157 should show purity of 98% or higher on HPLC testing